Noncontrast CT-Based Deep Learning for Predicting Hematoma Expansion Risk in Patients with Spontaneous Intracerebral Hemorrhage
NCCT-DL-HE
1 other identifier
observational
2,000
1 country
1
Brief Summary
Hematoma expansion is an independent predictor of poor prognosis and early neurological deterioration in patients with spontaneous intracerebral hemorrhage. Early identification of high-risk patients and timely targeted medical interventions may provide a crucial opportunity to limit hematoma growth and improve neurological outcomes. This study aims to develop an end-to-end deep learning model based on noncontrast computed tomography images to predict the risk of hematoma expansion in patients with spontaneous intracerebral hemorrhage. This model could serve as a valuable risk stratification tool for patients with hematoma expansion, facilitating targeted treatment and providing clinicians with streamlined decision-making support in emergency situations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 10, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
September 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedSeptember 19, 2024
August 1, 2024
6 days
September 10, 2024
September 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prediction of Hematoma Expansion
Proportion of patients with hematoma expansion
From the onset of ICH symptoms to 72 hours after baseline CT
Study Arms (2)
Hematoma Expansion Group
Hematoma Expansion Group
No Hematoma Expansion Group
Patients without hematoma expansion as defined in the study
Interventions
Observational study, no interventions involved
Eligibility Criteria
A multicenter retrospective cohort of 2000 patients with spontaneous intracerebral hemorrhage, including 500 cases of hematoma expansion and 1500 cases without hematoma expansion.
You may qualify if:
- Primary, spontaneous (non-traumatic) intracerebral hemorrhage (ICH).
- Age ≥ 18 years.
- Baseline CT performed within 24 hours of ICH symptom onset or last seen well (LSW).
- Follow-up CT within 72 hours.
You may not qualify if:
- Secondary ICH caused by trauma, vascular anomalies (e.g., aneurysm, cavernous angioma, arteriovenous malformation), brain tumor, or hemorrhagic transformation in brain infarction.
- Primary intraventricular hemorrhage (IVH).
- Surgical treatment with external ventricular drain placement or craniotomy.
- Obvious artifacts observed in CT images.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Qiang Yulead
- Xiangya Hospital of Central South Universitycollaborator
- The First Affiliated Hospital with Nanjing Medical Universitycollaborator
- Southwest Hospital, Chinacollaborator
- Liuzhou Workers' Hospitalcollaborator
Study Sites (1)
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
Related Publications (1)
Tran AT, Zeevi T, Haider SP, Abou Karam G, Berson ER, Tharmaseelan H, Qureshi AI, Sanelli PC, Werring DJ, Malhotra A, Petersen NH, de Havenon A, Falcone GJ, Sheth KN, Payabvash S. Uncertainty-aware deep-learning model for prediction of supratentorial hematoma expansion from admission non-contrast head computed tomography scan. NPJ Digit Med. 2024 Feb 6;7(1):26. doi: 10.1038/s41746-024-01007-w.
PMID: 38321131BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Sponsor-Investigator
Study Record Dates
First Submitted
September 10, 2024
First Posted
September 19, 2024
Study Start
September 25, 2024
Primary Completion
October 1, 2024
Study Completion
December 1, 2024
Last Updated
September 19, 2024
Record last verified: 2024-08